{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:48:57Z","timestamp":1786654137657,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi-Aventis US LLC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca PLC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim Corp USA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"Netherlands Organisation for Health Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJC Heart & Vasculature"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ijcha.2026.101961","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T14:41:54Z","timestamp":1782312114000},"page":"101961","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Lipid-lowering therapy omission at discharge and one-year outcomes after percutaneous coronary intervention: a real-world analysis of overall and elderly patients"],"prefix":"10.1016","volume":"65","author":[{"given":"Denise A.M.","family":"Peeters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva C.I.","family":"Woelders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanne","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaouad","family":"Azzahhafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean R.P.P.","family":"Chan Pin Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wout W.A.","family":"van den Broek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu Ying F.","family":"van de Pol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysun","family":"Cetinyurek-Yavuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patty J.C.","family":"Winkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Damman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasper J.P.","family":"Luijkx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter S.","family":"Remkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnoud W.J.","family":"van't Hof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurri\u00ebn M.","family":"ten Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert Jan M.","family":"van Geuns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcha.2026.101961_bb0005","author":"WHO"},{"issue":"11","key":"10.1016\/j.ijcha.2026.101961_bb0010","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.jacc.2012.02.082","article-title":"Obstructive coronary atherosclerosis and ischemic heart disease: an elusive link!","volume":"60","author":"Marzilli","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"issue":"38","key":"10.1016\/j.ijcha.2026.101961_bb0015","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC guidelines for the management of acute coronary syndromes: developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC)","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcha.2026.101961_bb0020","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehae177","article-title":"ESC guidelines for the management of chronic coronary syndromes","author":"Vrints","year":"2024","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.ijcha.2026.101961_bb0025","doi-asserted-by":"crossref","DOI":"10.1111\/eci.14323","article-title":"Ten-year clinical outcomes after drug-eluting stents implantation according to clinical presentation-insights from the DECADE cooperation","volume":"55","author":"Starnecker","year":"2025","journal-title":"Eur. J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.ijcha.2026.101961_bb0030","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2019","journal-title":"Eur. Heart J."},{"issue":"32","key":"10.1016\/j.ijcha.2026.101961_bb0035","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European atherosclerosis society consensus panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur. Heart J."},{"issue":"13","key":"10.1016\/j.ijcha.2026.101961_bb0040","first-page":"e771","article-title":"ACC\/AHA\/ACEP\/NAEMSP\/SCAI guideline for the management of patients with acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"151","author":"Rao","year":"2025","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.ijcha.2026.101961_bb0045","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/eurjpc\/zwaa047","article-title":"EU-wide cross-sectional observational study of lipid-modifying therapy use in secondary and primary care: the DA VINCI study","volume":"28","author":"Ray","year":"2020","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.ijcha.2026.101961_bb0050","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.atherosclerosis.2019.03.014","article-title":"Management of dyslipidaemia in patients with coronary heart disease: results from the ESC-EORP EUROASPIRE V survey in 27 countries","volume":"285","author":"De Backer","year":"2019","journal-title":"Atherosclerosis"},{"issue":"18","key":"10.1016\/j.ijcha.2026.101961_bb0055","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/j.jacc.2022.02.048","article-title":"High-intensity statin use among patients with atherosclerosis in the U.S","volume":"79","author":"Nelson","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcha.2026.101961_bb0060","article-title":"External validation of the GRACE risk score and the risk-treatment paradox in patients with acute coronary syndrome","volume":"9","author":"NMR","year":"2022","journal-title":"Open Heart"},{"key":"10.1016\/j.ijcha.2026.101961_bb0065","article-title":"Lipid-lowering therapy in patients with coronary heart disease: an Italian real-life survey. Results from the Survey on Risk FactOrs and CardiovascuLar secondary prEvention and drug strategieS (SOFOCLES) in Italy","author":"Aragona","year":"2024","journal-title":"Monaldi Arch. Chest Dis."},{"issue":"15","key":"10.1016\/j.ijcha.2026.101961_bb0070","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1001\/jama.291.15.1864","article-title":"Lipid-lowering therapy with statins in high-risk elderly PatientsThe treatment-risk paradox","volume":"291","author":"Ko","year":"2004","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.ijcha.2026.101961_bb0075","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-070827","article-title":"Effectiveness of lipid-lowering therapy on mortality and major adverse cardiovascular event outcomes in patients undergoing percutaneous coronary intervention: a network meta-analysis of randomised controlled trials","volume":"13","author":"Deng","year":"2023","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.ijcha.2026.101961_bb0080","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jacc.2007.06.063","article-title":"Statins for secondary prevention in elderly patients: a hierarchical bayesian meta-analysis","volume":"51","author":"Afilalo","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcha.2026.101961_bb0085","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1186\/s13063-015-1023-4","article-title":"A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results","volume":"16","author":"Kennedy-Martin","year":"2015","journal-title":"Trials"},{"issue":"16","key":"10.1016\/j.ijcha.2026.101961_bb0090","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1001\/jama.2023.4855","article-title":"Randomized trials vs real-world evidence: how can both inform decision-making?","volume":"329","author":"Sheldrick","year":"2023","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.ijcha.2026.101961_bb0095","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/eurheartj\/ehaa1011","article-title":"Low-density lipoprotein cholesterol reduction and statin intensity in myocardial infarction patients and major adverse outcomes: a Swedish nationwide cohort study","volume":"42","author":"Schubert","year":"2021","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.ijcha.2026.101961_bb0100","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s12471-025-01934-7","article-title":"Design and rationale of the south-East Netherlands heart registry (ZON-HR)","volume":"33","author":"Woelders","year":"2025","journal-title":"Neth. Hear. J."},{"issue":"10","key":"10.1016\/j.ijcha.2026.101961_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9103173","article-title":"Rationale and design of the future optimal research and care evaluation in patients with acute coronary syndrome (FORCE-ACS) registry: towards \u201cpersonalized medicine\u201d in daily clinical practice","volume":"9","author":"Chan Pin Yin","year":"2020","journal-title":"J. Clin. Med."},{"issue":"24","key":"10.1016\/j.ijcha.2026.101961_bb0110","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1161\/CIRCULATIONAHA.117.029289","article-title":"Standardized end point definitions for coronary intervention trials: the academic research Consortium-2 consensus document","volume":"137","author":"Garcia-Garcia","year":"2018","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.ijcha.2026.101961_bb0115","doi-asserted-by":"crossref","first-page":"e618","DOI":"10.1161\/CIR.0000000000000617","article-title":"Fourth universal definition of myocardial infarction","volume":"138","author":"Thygesen","year":"2018","journal-title":"Circulation"},{"issue":"10170","key":"10.1016\/j.ijcha.2026.101961_bb0120","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(18)31942-1","article-title":"Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials","volume":"393","author":"Armitage","year":"2019","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.ijcha.2026.101961_bb0125","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/clc.23902","article-title":"Prognosis of PCI in AMI setting in the elderly population: outcomes from the multicenter prospective e-ULTIMASTER registry","volume":"45","author":"Saada","year":"2022","journal-title":"Clin. Cardiol."},{"issue":"3","key":"10.1016\/j.ijcha.2026.101961_bb0130","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2174\/1573403X13666170426104611","article-title":"The anti-inflammatory effects of statins on coronary artery disease: an updated review of the literature","volume":"13","author":"Diamantis","year":"2017","journal-title":"Curr. Cardiol. Rev."},{"issue":"13","key":"10.1016\/j.ijcha.2026.101961_bb0135","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.285.13.1711","article-title":"Effects of atorvastatin on early recurrent ischemic events in acute coronary SyndromesThe MIRACL study: a randomized controlled trial","volume":"285","author":"Schwartz","year":"2001","journal-title":"JAMA"},{"issue":"24","key":"10.1016\/j.ijcha.2026.101961_bb0140","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1016\/j.jacc.2009.09.010","volume":"54","author":"Gibson","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"issue":"15","key":"10.1016\/j.ijcha.2026.101961_bb0145","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/eurjpc\/zwae255","article-title":"Prognostic impact of high-intensity lipid-lowering therapy under-prescription after acute myocardial infarction in women","volume":"31","author":"Weizman","year":"2024","journal-title":"Eur. J. Prev. Cardiol."}],"container-title":["IJC Heart & Vasculature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906726000953?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906726000953?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:24:09Z","timestamp":1786652649000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352906726000953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":29,"alternative-id":["S2352906726000953"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcha.2026.101961","relation":{},"ISSN":["2352-9067"],"issn-type":[{"value":"2352-9067","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipid-lowering therapy omission at discharge and one-year outcomes after percutaneous coronary intervention: a real-world analysis of overall and elderly patients","name":"articletitle","label":"Article Title"},{"value":"IJC Heart & Vasculature","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcha.2026.101961","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101961"}}